SG11202007288VA - Transforming growth factor beta-resistant natural killer cells - Google Patents
Transforming growth factor beta-resistant natural killer cellsInfo
- Publication number
- SG11202007288VA SG11202007288VA SG11202007288VA SG11202007288VA SG11202007288VA SG 11202007288V A SG11202007288V A SG 11202007288VA SG 11202007288V A SG11202007288V A SG 11202007288VA SG 11202007288V A SG11202007288V A SG 11202007288VA SG 11202007288V A SG11202007288V A SG 11202007288VA
- Authority
- SG
- Singapore
- Prior art keywords
- growth factor
- natural killer
- transforming growth
- killer cells
- factor beta
- Prior art date
Links
- 102000004887 Transforming Growth Factor beta Human genes 0.000 title 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 title 1
- 210000000822 natural killer cell Anatomy 0.000 title 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4613—Natural-killer cells [NK or NK-T]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46443—Growth factors
- A61K39/464434—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0646—Natural killers cells [NK], NKT cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/48—Blood cells, e.g. leukemia or lymphoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/55—Lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/99—Coculture with; Conditioned medium produced by genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862623682P | 2018-01-30 | 2018-01-30 | |
| PCT/US2019/015617 WO2019152387A1 (en) | 2018-01-30 | 2019-01-29 | Transforming growth factor beta-resistant natural killer cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202007288VA true SG11202007288VA (en) | 2020-08-28 |
Family
ID=67478491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007288VA SG11202007288VA (en) | 2018-01-30 | 2019-01-29 | Transforming growth factor beta-resistant natural killer cells |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200368281A1 (de) |
| EP (1) | EP3746118A4 (de) |
| JP (1) | JP2021512164A (de) |
| KR (1) | KR20200118449A (de) |
| CN (1) | CN111818941A (de) |
| AU (1) | AU2019213678A1 (de) |
| BR (1) | BR112020015490A2 (de) |
| CA (1) | CA3090096A1 (de) |
| IL (2) | IL276374B2 (de) |
| MX (1) | MX2020008044A (de) |
| RU (1) | RU2020127722A (de) |
| SG (1) | SG11202007288VA (de) |
| WO (1) | WO2019152387A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023517220A (ja) * | 2020-03-11 | 2023-04-24 | リサーチ インスティテュート アット ネイションワイド チルドレンズ ホスピタル | 微生物感染症の治療のためのｎｋ細胞およびそれらの使用 |
| EP4142752A1 (de) * | 2020-04-30 | 2023-03-08 | Research Institute at Nationwide Children's Hospital | Überwindung der immunsuppression mit tgf-beta-resistenten nk-zellen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2058388A1 (de) * | 2007-10-05 | 2009-05-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nicht-konventionelle NKT-Zellen zur Verwendung in der Krebstherapie |
| CN105143441B (zh) * | 2014-01-13 | 2019-11-08 | 张明杰 | 用带有活性因子的细胞空壳作为淋巴细胞体外培养增效剂的制备及其应用方法 |
| BR112017008696A2 (pt) * | 2014-10-27 | 2017-12-26 | Univ Central Florida Res Found Inc | métodos e composições para células exterminadoras naturais |
| JP2018526013A (ja) * | 2015-09-01 | 2018-09-13 | イネイト・テューマー・イミュニティ・インコーポレイテッドＩｎｎａｔｅ Ｔｕｍｏｒ Ｉｍｍｕｎｉｔｙ， Ｉｎｃ． | 免疫または免疫抑制性サイトカインに対する抵抗性が増大した免疫細胞およびその使用 |
| EP3349770A1 (de) * | 2015-09-14 | 2018-07-25 | Regents of the University of Minnesota | Nk-zellen mit adaptivem phänotyp sowie verfahren zur herstellung und zur verwendung |
-
2019
- 2019-01-29 WO PCT/US2019/015617 patent/WO2019152387A1/en unknown
- 2019-01-29 IL IL276374A patent/IL276374B2/en unknown
- 2019-01-29 BR BR112020015490-3A patent/BR112020015490A2/pt unknown
- 2019-01-29 CA CA3090096A patent/CA3090096A1/en active Pending
- 2019-01-29 AU AU2019213678A patent/AU2019213678A1/en active Pending
- 2019-01-29 MX MX2020008044A patent/MX2020008044A/es unknown
- 2019-01-29 US US16/966,367 patent/US20200368281A1/en active Pending
- 2019-01-29 JP JP2020562093A patent/JP2021512164A/ja active Pending
- 2019-01-29 CN CN201980016864.3A patent/CN111818941A/zh active Pending
- 2019-01-29 RU RU2020127722A patent/RU2020127722A/ru unknown
- 2019-01-29 KR KR1020207024676A patent/KR20200118449A/ko not_active Application Discontinuation
- 2019-01-29 EP EP19747119.6A patent/EP3746118A4/de active Pending
- 2019-01-29 SG SG11202007288VA patent/SG11202007288VA/en unknown
- 2019-01-29 IL IL309656A patent/IL309656A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL309656A (en) | 2024-02-01 |
| US20200368281A1 (en) | 2020-11-26 |
| CA3090096A1 (en) | 2019-08-08 |
| AU2019213678A1 (en) | 2020-09-03 |
| BR112020015490A2 (pt) | 2021-03-23 |
| WO2019152387A1 (en) | 2019-08-08 |
| MX2020008044A (es) | 2020-12-10 |
| EP3746118A4 (de) | 2021-11-24 |
| CN111818941A (zh) | 2020-10-23 |
| RU2020127722A (ru) | 2022-02-28 |
| IL276374B2 (en) | 2024-05-01 |
| KR20200118449A (ko) | 2020-10-15 |
| IL276374A (en) | 2020-09-30 |
| IL276374B1 (en) | 2024-01-01 |
| JP2021512164A (ja) | 2021-05-13 |
| EP3746118A1 (de) | 2020-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3562492A4 (de) | Genetisch modifizierte natürliche killerzellen | |
| IL285543A (en) | Natural killer cells modified for immunotherapy | |
| IL258666A (en) | Natural killer cells and ilc3 cells and their use | |
| EP3240552A4 (de) | Natürliche killerzellen und verwendungen davon | |
| EP3223856A4 (de) | Verfahren und zusammensetzungen für natürliche killerzellen | |
| IL275780A (en) | Ear formulations of growth factor | |
| EP3686274A4 (de) | Verfahren zur herstellung einer natürlichen killerzelle und verwendung davon | |
| IL285039A (en) | Preparations and methods for stimulating natural killer cells | |
| GB201704953D0 (en) | Natural killer cells | |
| EP3296620A4 (de) | Pflanzenwachstumslampe | |
| EP3524054A4 (de) | Pflanzenwachstumsregulator | |
| IL277467A (en) | A method for producing natural killer cells | |
| IL276374A (en) | Natural killer cells are resistant to transforming growth factor beta | |
| GB201810486D0 (en) | Natural killer cells | |
| EP3941493A4 (de) | Durch umschaltbaren chimären antigenrezeptor manipulierte humane natürliche killerzellen | |
| PT3589728T (pt) | Células assassinas naturais | |
| EP3720965A4 (de) | Pflanzen mit verbessertem wachstum | |
| EP4083186A4 (de) | Zellwachstumsregulator | |
| EP3849529A4 (de) | Künstliches periost | |
| EP3802797A4 (de) | Verfahren zur herstellung von natürlichen killerzellen und deren verwendungen | |
| EP3532621A4 (de) | Pflanzen mit verbessertem wachstum | |
| EP3790891A4 (de) | Produkte und verfahren natürlicher killerzellen | |
| FI3876700T3 (fi) | Sammalkasvualusta | |
| GB202102206D0 (en) | Plant growth chamber | |
| EP3577457A4 (de) | Von gameten sekretierte wachstumsfaktoren |